- Home
- KNSA vs FORTY Comparison
KNSA vs FORTY Comparison
Compare KNSA & FORTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- FORTY
- Stock Information
- Founded
- KNSA 2015
- FORTY 1985
- Country
- KNSA United Kingdom
- FORTY Israel
- Employees
- KNSA N/A
- FORTY N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- FORTY EDP Services
- Sector
- KNSA Health Care
- FORTY Technology
- Exchange
- KNSA Nasdaq
- FORTY Nasdaq
- Market Cap
- KNSA 2.6B
- FORTY 2.3B
- IPO Year
- KNSA 2018
- FORTY 1997
- Fundamental
- Price
- KNSA $41.77
- FORTY $149.75
- Analyst Decision
- KNSA Strong Buy
- FORTY
- Analyst Count
- KNSA 6
- FORTY 0
- Target Price
- KNSA $51.33
- FORTY N/A
- AVG Volume (30 Days)
- KNSA 461.3K
- FORTY 563.0
- Earning Date
- KNSA 10-28-2025
- FORTY 11-20-2025
- Dividend Yield
- KNSA N/A
- FORTY 0.93%
- EPS Growth
- KNSA N/A
- FORTY N/A
- EPS
- KNSA 0.47
- FORTY 4.53
- Revenue
- KNSA $597,973,000.00
- FORTY $3,016,039,000.00
- Revenue This Year
- KNSA $62.63
- FORTY N/A
- Revenue Next Year
- KNSA $29.93
- FORTY N/A
- P/E Ratio
- KNSA $89.00
- FORTY $32.41
- Revenue Growth
- KNSA 55.68
- FORTY 11.45
- 52 Week Low
- KNSA $17.82
- FORTY $80.15
- 52 Week High
- KNSA $42.93
- FORTY $169.03
- Technical
- Relative Strength Index (RSI)
- KNSA 64.60
- FORTY 57.47
- Support Level
- KNSA $39.61
- FORTY $137.45
- Resistance Level
- KNSA $42.93
- FORTY $169.03
- Average True Range (ATR)
- KNSA 1.43
- FORTY 1.85
- MACD
- KNSA 0.19
- FORTY 0.66
- Stochastic Oscillator
- KNSA 79.30
- FORTY 43.54
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.